Etienne Brain Clinical Oncology Society of Australia Annual Scientific Meeting 2023

Etienne Brain

Etienne Brain, MD with a board certification in medical oncology (1993), works at Institut Curie since 1998. After a fellowship in Boston in 1996 (Dana Farber Cance Institute and Boston University), he obtained a Ph.D in 2005. He was empowered to supervise research by Versailles/Saint-Quentin University in 2010. He got a diploma in Management and Health Economics from Bocconi University (Milan, IT, 2015). For more than 20 years, he has been very involved in clinical research for breast cancer and for cancer in older patients. He has chaired the group GERICO (Unicancer) and the Intergroup DIALOG labeled by the INCa, both dedicated to clinical research on cancer in older persons. He has chaired the breast cancer group of the European Organisation for Research and Treatment of Cancer (EORTC), and he is the EORTC Secretary General since 2021. He is an executive board member of the Breast International Group. The management of breast cancer in older patients is the key issue addressed by his works, taking into account both competitive risks for mortality and frailty in the treatment decision making process. This is best epitomized by the ASTER 70s program. This is the largest clinical trial (2000 women aged 70 and older) ever conducted on the role of adjuvant chemotherapy for luminal breast cancer, the most frequent phenotype in this age group. Dr Brain presented the results of ASTER 70s at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago in June 2022, after receiving the B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology. He as also received the Michel Hery geriatric oncology Award at the Monaco Age Oncology conference 2023.